Edition:
United States

Yield10 Bioscience posts Q3 loss $0.59/shr from continuing operations


Thursday, 9 Nov 2017 04:03pm EST 

Nov 9 (Reuters) - Yield10 Bioscience Inc :Yield10 Bioscience announces third quarter 2017 financial results.Q3 loss per share $0.59 from continuing operations.Q3 revenue $200,000 versus $500,000.Yield10 Bioscience Inc - expects to use about $8.0 million to $8.5 million in cash for FY 2017, including anticipated payments for restructuring costs​.Yield10 Bioscience Inc - expects current cash resources will be sufficient to fund operations & meet obligations into Q1 2018​.Yield10 - "the ‍company's present capital resources raise substantial doubt, however, about company's ability to continue as a going concern"​. 

Related Company News

Company Quote

1.39
-0.05 -3.47%
18 Oct 2018